PortfoliosLab logo

Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

Equity · Currency in USD · Last updated Aug 11, 2022

Company Info

ISINVGG111961055
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$147.11
Year Range$83.14 - $148.48
EMA (50)$142.84
EMA (200)$132.62
Average Volume$808.17K
Market Capitalization$10.52B

BHVNShare Price Chart


Chart placeholderClick Calculate to get results

BHVNPerformance

The chart shows the growth of $10,000 invested in Biohaven Pharmaceutical Holding Company Ltd. in May 2017 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $86,535 for a total return of roughly 765.35%. All prices are adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%MarchAprilMayJuneJulyAugust
6.73%
-4.35%
BHVN (Biohaven Pharmaceutical Holding Company Ltd.)
Benchmark (^GSPC)

BHVNReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M1.07%7.97%
6M12.44%-6.88%
YTD6.75%-11.66%
1Y24.91%-5.01%
5Y44.25%11.56%
10Y50.65%11.37%

BHVNMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-3.58%-10.66%-0.12%-24.80%61.19%1.38%0.21%0.75%
2021-0.57%-0.28%-19.57%9.88%15.85%11.59%29.80%4.15%5.84%2.45%-21.14%22.78%
2020-10.93%-8.93%-22.94%38.41%32.63%17.03%-12.41%-1.01%2.56%19.15%14.83%-3.64%
20193.00%15.46%17.03%16.28%-5.66%-22.44%-1.71%-8.95%6.46%10.07%24.83%-5.02%
201828.09%-1.94%-23.99%13.20%20.03%12.91%-12.65%9.68%-0.82%-3.99%-5.71%8.80%
201748.29%-0.83%3.04%38.78%4.56%-19.58%-23.05%16.65%

BHVNSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Biohaven Pharmaceutical Holding Company Ltd. Sharpe ratio is 0.41. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-0.500.000.501.001.50MarchAprilMayJuneJulyAugust
0.41
-0.25
BHVN (Biohaven Pharmaceutical Holding Company Ltd.)
Benchmark (^GSPC)

BHVNDividend History


Biohaven Pharmaceutical Holding Company Ltd. doesn't pay dividends

BHVNDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-0.92%
-12.22%
BHVN (Biohaven Pharmaceutical Holding Company Ltd.)
Benchmark (^GSPC)

BHVNWorst Drawdowns

The table below shows the maximum drawdowns of the Biohaven Pharmaceutical Holding Company Ltd.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Biohaven Pharmaceutical Holding Company Ltd. is 58.95%, recorded on Mar 16, 2020. It took 56 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-58.95%Jun 10, 2019194Mar 16, 202056Jun 4, 2020250
-46.51%Sep 12, 201761Dec 6, 2017129Jun 13, 2018190
-44.01%Nov 4, 2021128May 9, 2022
-34.78%Nov 19, 202088Mar 29, 202151Jun 10, 2021139
-30.81%Jul 9, 2018117Dec 21, 201833Feb 11, 2019150
-24.26%Jul 9, 202046Sep 11, 202020Oct 9, 202066
-14.72%Jun 1, 20177Jun 9, 20175Jun 16, 201712
-13.87%Jul 29, 20219Aug 10, 202111Aug 25, 202120
-13.46%Apr 26, 201929Jun 6, 20191Jun 7, 201930
-12.16%Jun 22, 201730Aug 3, 201711Aug 18, 201741

BHVNVolatility Chart

Current Biohaven Pharmaceutical Holding Company Ltd. volatility is 3.91%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%300.00%350.00%MarchAprilMayJuneJulyAugust
3.91%
16.23%
BHVN (Biohaven Pharmaceutical Holding Company Ltd.)
Benchmark (^GSPC)